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ABSTRACT 
 Systemic lupus erythematosus (SLE), or lupus, is a rare autoimmune disease in 
which the antibodies that are formed in the body attack healthy tissues and organs. The 
most prevalent physical manifestation of the illness is fatigue. Fatigue often plagues 
patients with no warning and without leaving a trace of measurable evidence. The issue 
of fatigue’s invisibility and the difficulties of communicating the experience of fatigue 
has been shown to impact relationships with friends, family, and physicians. It is 
important for patients to understand their condition in order to better identify their own 
triggers, manage their condition, and communicate their symptoms to friends, families, 
and other medical professionals. The study sought to explore the lived experience of 
women who have lupus, describe the impact of symptom invisibility on social support 
and patient-doctor relationships, identify effective strategies in communicating and 
managing the condition, and describe the broad range of life changes associated with the 
disease. The study utilized in-depth, semi-structured interviews to gather detailed 
information from eleven women with lupus. Six overarching themes emerged from the 
data: difficulties with diagnosis, discovering lupus is a process, managing lupus, social 
impact of lupus, communicating the experience, and limitations of the healthcare system. 
Symptom invisibility was not frequently cited as the cause of any interpersonal problems 
faced by the participants. Rather, the results suggest that the current healthcare system in 
the United States may not be equipped to adequately care for patients with lupus. This 
study provides insight for recommendations to patients with lupus and may inform 
cultural and policy changes necessary to improve healthcare delivery.  
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INTRODUCTION 
Background 
Systemic lupus erythematosus (SLE), or lupus, is a rare autoimmune disease in 
which the antibodies that are formed in the body attack healthy tissues and organs 
(Agarwal, Barnes, & Kumar, 2015; Jolly et al., 2012; Pettersson, Möller, Svenungsson, 
Gunnarsson, & Welin Henriksson, 2010). It is estimated that in the US, SLE affects about 
40-50 individuals in every 100,000 (Lawrence et al., 1998), predominately women (9 out 
of 10). In addition, women of color are 2 to 4 times more likely to be diagnosed with 
lupus than Caucasian women (Auerbach, Beckerman, & Blanco, 2013; Ortiz-Hendricks, 
2012). The disease is marked by a series of exacerbations (flares) and remissions, and 
also by its unpredictable nature (Agarwal et al., 2015; Auerbach et al., 2013; Auerbach & 
Beckerman, 2012; Squance, Reeves, & Bridgman, 2014). Although what causes lupus is 
unknown, researchers suspect that genetic, environmental, and hormonal factors all 
contribute to the development of the disease (Kyttaris, 2010). The clinical manifestations 
are caused by inflammatory processes that affect different organs and if untreated may 
cause permanent damage to organs and tissues, most commonly to the skin, kidneys, or 
joints (Agarwal et al., 2015; Auerbach et al., 2013; Squance et al., 2014; Kyttaris, 2010). 
The most common symptoms experienced are joint pain and fatigue which contribute to 
poor quality of life (Auerbach et al., 2013; Neill, Belan, & Ried, 2006; Pettersson et al., 
2010). 
Fatigue is typically the most prevalent physical manifestation of the illness, often 
plaguing patients with no warning, and without leaving a trace of measurable evidence 
(Auerbach et al., 2013; Kralik, Telford, Price, & Koch, 2005; Neill et al., 2006; 
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Pettersson et al., 2010; Squance et al., 2014). Fatigue has been described as the most 
chronic symptom experienced by 50 – 100% of patients with lupus (Del Pino-Sedeno et 
al., 2016; Kozora, Ellison, & West, 2006). For example, between 80 – 90% of women 
with SLE (N  = 20) reported moderate to severe mental and physical fatigue in the past 
month (Tench, McCurdie, White, & D’Cruz, 2000). Due to fatigue’s chronicity, it is not 
uncommon for patients to suffer from lupus-related depression and anxiety (Auerbach et 
al., 2013; Auerbach & Beckerman, 2012; Jump et al., 2005).  In fact, a study comparing 
depression in patients with SLE (n = 87) versus patients with other chronic disorders (n = 
78) such as fibromyalgia and heart disease found that those with SLE were more likely to 
report a diagnosis of depression compared to the control group (40% v. 7%, respectively) 
(Jolly et al., 2012).  In addition, patients with lupus are likely to experience lupus-related 
depression and anxiety, usually measured using the SLE needs questionnaire (1 = “no 
need” and 5 = “high need”). Auerbach et al (2013) found that compared to participants 
who did not experience fatigue, patients who experienced fatigue report significantly 
higher need for support due to depression (3.2 v. 3.7) and anxiety (3.2 v. 3.8). Overall, 
the evidence suggests that fatigue impacts patients’ mental health thus increasing a need 
for further assistance.  
Furthermore, the fact that fatigue does not have a clear sign nor an objective 
measure (i.e., it is an invisible symptom), may further impact patients’ quality of life. A 
discussion group of 30 women who suffer from chronic fatigue reported seeming 
unreliable to friends/family as a consequence of fatigue’s invisibility (Kralik et al., 2005). 
Respondents expressed great difficulty communicating to others how much fatigue 
affects them (Kralik et al., 2005). The issue of fatigue’s invisibility and the difficulties of 
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communicating the experience of fatigue has also been shown to impact the relationship 
with physicians (Berrios-Rivera et al., 2006; Hale et al., 2006; Kralik et al., 2005; Street, 
Makoul, Arora, & Epstein, 2009; Ward et al., 2003). In order to understand the extent of 
the problem, we will explore the experience of symptom invisibility in different 
conditions.  
Defining Invisibility 
A chronic invisible illness is described as an ongoing condition that may or may 
not be treatable and is often forgotten, ignored, trivialized, dismissed, and/or poorly 
understood (Jefferies & Clifford, 2012; Vickers, 2000). Disclosing an invisible disease to 
others does not guarantee that people will understand the experience of having that 
condition (Hoppe, 2010). Rather, patients might still be subject to ineffective and/or 
unwanted social support (Brennan & Creaven, 2015). 
Invisibility of a disease occurs due to certain nuances unique to that illness which 
might interfere with a patient receiving proper care (Ciribassi & Patil, 2016; Gysels & 
Higginson, 2008; Hoppe, 2010; Jefferies & Clifford, 2012). Patients with sickle-cell 
disease (N = 70) reported that their pain, an invisible symptom, is often challenged by 
healthcare professionals (HCPs). They attribute this dismissive attitude of HCPs to the 
stereotype that African-Americans, the group most afflicted with sickle-cell disease, 
abuse drugs. Although doctors often rely on patients’ self-report to estimate pain severity, 
many participants discussed the fact that when they encounter new doctors, their 
expertise tends to overshadow the patient’s expertise on their own medical history; 
therefore, patients’ pain would remain untreated (Ciribassi & Patil, 2016). 
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Similarly, a qualitative study sought to analyze the lived experience of 
breathlessness, an invisible symptom, among patients with chronic obstructive pulmonary 
disease (COPD) and found that many of the participants (N = 18) perceived a lack of 
response from HCPs due to the fact that COPD is seen as an illness in which the patient is 
responsible for its occurrence (i.e. because of smoking). For that reason, patients with 
COPD reported not receiving treatment unless they had an acute episode of 
breathlessness in front of HCPs (Gysels & Higginson, 2008). 
In a study using qualitative interviews to investigate the experiences of thirteen 
women with cancer of the vulva, Jefferies & Clifford (2012) attribute the invisibility of 
the disease to the private location of the tumors in addition to the general lack of 
understanding about vulvar cancer. As a result of suffering a “taboo” condition (i.e. 
cancer of the vulva), many of the women felt their informational needs regarding their 
diagnosis and what it entailed were not met. They reported feeling shock when met with 
physical, psychological, and sexual difficulties following the surgery to remove the 
tumor(s), and believed they were not sufficiently warned about these difficulties by their 
physicians (Jefferies & Clifford, 2012). The evidence suggests that “invisible” 
conditions/symptoms tend to be more difficult to communicate and manage.  
Poor Patient-Provider Communication 
It is important for patients to understand their condition in order to better identify 
their own triggers, manage their condition, and communicate their symptoms to friends, 
families, and medical professionals (Jefferies & Clifford, 2012). In the case of SLE, the 
educational process seems hindered by a limited understanding of the condition among 
physicians as well as poor communication practices that harm the patient-provider 
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partnership (Hale et al., 2006; Kralik et al., 2005; Squance et al., 2014). For example, 
women with SLE (N = 10) have reported that prior to diagnosis, they felt doctors labeled 
them as “malingering” due to frequent visits resulting in no new developments (Hale et 
al., 2006). Once diagnosed, they felt their symptoms were finally legitimized, however, 
they reported not having an opportunity to sit down with their doctor to discuss causality, 
treatment, and disease progression. Overall, they believed health care professionals 
(HCPs) not specialized in SLE lacked a basic understanding of the illness. The authors 
suggest these issues might occur due to poor communication between HCPs and patients, 
as well as HCPs underestimating the impact that the unpredictable nature of the disease 
may have on the patient (Hale et al., 2006).  
Squance et al (2014) found similar dismissing experiences among 101 women 
with lupus. Participants reported that it was likely for lupus flares to be dismissed by 
HCPs and general practitioners (GPs). Participants speculated that GPs expect the 
objective flare assessments and the subjective experience of a flare to occur 
simultaneously. While doctors tend to rely on biomarker measures and treatment 
changes, SLE patients relied more on the subjective experience of change and will report 
a flare if there is a new symptom or an exacerbation of an existing symptom. Of the 101 
females with SLE in the study, only 25% of them reported they always told their GP 
when they were having a flare. One fifth (20%) of the women would only tell their 
doctors if they were already going to see them or if they deemed their flare was severe 
enough to report (Squance et al., 2014). Participants expressed resignation with the fact 
that it is difficult to get an appointment with the doctor as soon as a flare occurs, and with 
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the discrepancy between a patient definition and a doctor definition of a flare (Squance et 
al., 2014).  
Women who suffer from fatigue due to other chronic conditions also believed 
their physicians had limited knowledge of what it means to experience fatigue (Kralik et 
al., 2005). This limited knowledge also seems to lead to discrepancies in the definition of 
fatigue used by patients and their HCPs (Kralik et al, 2005). Although these women 
considered their experience of fatigue as severe and of significant importance, they often 
felt HCPs invalidated their concerns and were unable to offer support or treatment. The 
discounting of their symptoms resulted in internalizing the burden of fatigue instead of 
reporting their complaints and receiving appropriate medical treatment. Because of their 
fatigue, participants struggled to maintain concentration during social interaction, which 
sometimes resulted in social isolation (Kralik et al., 2005).  
How Lack of Information Interferes with Appropriate Treatment 
Waldron et al (2011) examined eight focus groups of patients with lupus (N = 43), 
in which participants reported that the lack of information about lupus after diagnosis 
increased feelings of isolation, because they were unable to effectively communicate their 
symptoms to their family members. Complaints concerning information about the disease 
were primarily attributed to the limited information provided without the opportunity to 
speak to a health professional one-on-one. Patients believed the information they received 
did not equip them with the knowledge or skills necessary to manage their lupus-related 
symptoms. In fact, they were unable to recognize what symptoms were indicative of a 
flare-up (Waldron et al., 2011). Furthermore, some reported they were not informed 
about the purpose of each medication they were prescribed, which consequently 
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discouraged them from taking the medication (Waldron et al., 2011). While 
miscommunication between patients and HCPs has been shown to result in many 
negative consequences for the patient (Jefferies & Clifford, 2012; Kralik et al., 2005; 
Raine, Carter, Sensky, & Black, 2004; Squance et al., 2014; Waldron et al., 2011), a 
positive relationship between the patient and the HCP is integral to promoting better 
health outcomes throughout the lifetime of women living with lupus (Bennett, Fuertes, 
Keitel, & Phillips, 2011; Berrios-Rivera et al., 2006; Street et al., 2009; Ward et al., 
2003). 
Benefits of Positive Patient-Doctor Working Alliance 
There is evidence linking a positive working alliance with improved patient health 
(Anderson, 2002) and lower symptom burden (Little et al., 2001) across various medical 
concerns (Bennett et al., 2011; Berrios-Rivera et al., 2006; Martin, Jahng, Golin, & 
DiMatteo, 2003; O’Malley, Sheppard, Schwartz, & Mandelblatt, 2004; Safran et al., 
1998; Viller F, Guillemin F, Briançon S, Moum T, Suurmeijer T, van den Heuvel, 1999; 
Ward et al., 2003). A working alliance between the patient and the HCP intends to 
promote agreement on treatment goals as well as tasks to achieve those goals through a 
collaborative approach, which promotes patient trust in the HCP (Bennett et al., 2011). A 
cross-sectional observational study of adults, employed by the Commonwealth of 
Massachusetts (N = 7,204), found that patient trust in physicians was one of the stronger 
predictors of patient adherence (Safran et al., 1998). In addition, another cross-sectional 
study determined high trust in physicians among low-income African-American women 
(N = 961) was associated with the use of nine different types of preventive clinical 
services (O’Malley et al., 2004). Among patients with lupus and rheumatoid arthritis 
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(RA) (n = 32 & n = 70, respectively), patient trust was associated with physician 
sensitivity to patient concerns (Berrios-Rivera et al., 2006). Satisfactory communication 
with HCPs among patients with RA was related to consistently adhering to a medication 
regimen [OR 0.3 (0.1 – 0.8, p = .03)] and more knowledge about RA and RA treatment 
[OR 0.4 (0.2 – 0.8, p = .03)] (Viller et al., 1999). An overall positive working alliance 
between patients with SLE (N = 193) and their physicians was also indirectly related to 
greater health-related quality of life via treatment satisfaction and directly related to 
treatment adherence (Bennett et al., 2011). Further, patient involvement in the decision-
making process was associated with less organ damage in 68 patients with lupus over a 
4.7-year follow-up (Ward et al., 2003).  Finally, a clinical encounter with a physician 
who consistently answered patient concerns (β = .22, p < .01), used open-ended questions 
(β = .49, p < .001), and offered fewer alternatives versus too many alternatives (β = .21, p 
< .01), led to patient satisfaction among 128 patients with type II diabetes (Martin et al., 
2003). In summary, it is essential for patients to have a positive and collaborative 
relationship with their physician since extensive evidence suggests such a relationship 
leads to a number of beneficial outcomes for the patient.  
Importance of Social Support 
Along with support from medical professionals, there is also evidence that support 
from social relationships is related to improved mental health status directly and 
indirectly through stress buffering (Thoits, 2011). For instance, patients with cancer 
experienced a reduction in anxiety when high social support significantly interacted with 
high optimism (β = .15, p = .02) (Applebaum et al., 2014). Better mental health is 
beneficial for patients because evidence has shown it is predictive of adherent behaviors 
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(McKellar, Humphreys, & Piette, 2004; Thumboo et al., 2000). For example, McKellar et 
al (2004) used structural equation modeling to confirm a direct relationship between 
lower depressive symptoms and engaging in diabetes self-care adherence, such as 
following a diet and medication regimen among 307 women with type 2 diabetes. 
Specifically, in patients with lupus (N = 90), a 6-month follow-up showed that having 
greater family support was associated with improved mental health scores (β = 1.77, p = 
.002) (Thumboo et al., 2000). In patients with lupus (N = 97), (Auerbach et al., 2013) 
having many friends to rely on decreased the need for support due to depression (β = - 
1.70, p < .01) and anxiety (β = - 1.12, p < .05). In addition, severe depressive symptoms 
in patients with SLE (N = 834) strongly predicted low adherence [OR 1.45 (1.04 – 2.04, p 
< .001)] (Julian et al., 2009). Overall when patients have a solid social support system, it 
improves their mental health status (Applebaum et al., 2014; Auerbach et al., 2013; 
Thoits, 2011; Thumboo et al., 2000).  A good mental health status not only improves 
their psychological wellbeing, but also promotes self-care and medication adherence 
(Auerbach et al., 2013; Julian et al., 2009; McKellar et al., 2004).   
Although social support and positive patient-doctor relationships predict better 
self-care behaviors (Auerbach et al., 2013; Bennett et al., 2011; McKellar et al., 2004; 
Safran et al., 1998), the inability of patients with lupus to effectively communicate their 
symptoms to others may contribute to misunderstandings about the severity of the disease 
among friends, families, and medical professionals, because lupus symptoms do not 
always display external clinical signs (Agarwal et al., 2015; Hale et al., 2006; Jefferies & 
Clifford, 2012; Kralik et al., 2005; Squance et al., 2014; Waldron et al., 2011). 
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Purpose of Study 
This study aims to: 1) describe the lived experience of women who have lupus; 2) 
describe the impact of invisibility on their perceived social support and patient-doctor 
relationships; 3) identify effective strategies in communicating their experience with the 
condition; and finally 4) identify effective strategies on how to manage lupus and the 
broad range of life changes associated with the disease. To achieve these aims we will 
utilize a qualitative approach. 
METHODS 
Study Design 
There is a remarkable lack of information about the experiences of women with 
SLE. Given this limited information available, a phenomenological qualitative approach 
is ideal to explore and shed light onto the experiences of women with SLE. This method 
allows the researcher to gather detailed information on each participant and explore their 
perspectives, as the experts of their own experiences. Qualitative methodology also gives 
a voice to people whose voices are hardly heard, and provides a foundation for the 
development of theories and hypotheses based on their reported experiences (Sofaer, 
1999). In qualitative studies, the role of the researcher is to facilitate the process in which 
participants identify their views. During the data analysis process, the views of the 
participants are subjected to some degree of interpretation; however, the aim throughout 
the process is to remain faithful to the meanings and intentions of the participants 
(Creswell, Hanson, Clark Plano, & Morales, 2007). 
Individual in-depth interviews are widely used by healthcare researchers to co-
create meaning with interviewees by reconstructing perceptions of events and 
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experiences related to health and healthcare delivery. These interviews are able to inform 
a wide range of research questions such as what treatment patients with chronic back pain 
expect from pain treatment centers (Walker, Holloway, & Sofaer, 1999) and why 
adolescents with food allergies fail to adhere to treatment instructions (Herbert, Lin, 
Matsui, Wood, & Sharma, 2015). In general, the qualitative approach requires the basic 
research question to be focused so that a relatively homogenous group will have shared 
experiences about the topic. The basic question can be followed by 5 – 10 more specific 
questions to delve more deeply into different aspects of the research issue (Crabtree & 
Miller, 2002).  
In-depth Interview 
Interview questions were designed to elicit the experiences along the life-cycle of 
patients with lupus; starting with the process of being diagnosed with lupus, the initial 
education about the diagnosis, the challenges of communicating their symptoms to their 
physicians and members of their social network, the impact of their symptoms on their 
social interactions, and the key management strategies they devised through the process. 
Several studies have reported the issue of invisibility as one of the challenges of women 
with SLE; therefore, we were interested to hear in particular how the invisibility of their 
symptoms has affected their experiences. Main questions and probes were used to gather 
this information; the main questions asked them to describe the timeline of their illness, if 
and how others help them manage their symptoms, to describe the working relationship 
with their physician, and to share their thoughts about the quality of information they 
have received about lupus care from HCPs (Appendix C). Understanding and identifying 
12 
 
the successful strategies developed through their lived experiences with lupus could 
inform educational interventions for HCPs as well as newly diagnosed patients.  
Survey 
Demographic information to characterize the study participants was collected 
including: age, race/ethnicity, marital status, employment status, family income, number 
of members in their family including themselves, a single-item question assessing general 
self-reported health, age of diagnosis, and what type(s) of lupus they have. Responses for 
race/ethnicity were left open-ended, allowing participants to describe their race/ethnic 
identity in their own words. The single-item question used by the Rand Corporation and 
the CDC assessing general self-reported health asked participants to finish the statement, 
“Would you say that in general your health is,” Poor, Fair, Good, Very Good, or 
Excellent (Hays & Morales, 2001; Center for Disease Control and Prevention, 2000). 
However, we did not instruct participants to answer the question in relation to other 
individuals with lupus or the general population; therefore, it is possible that the reference 
point for participants varied from person to person. 
Measures 
To describe disease severity, each participant filled out the Brief Index of Lupus 
Damage (BILD) questionnaire (Yazdany et al., 2011), the Systemic Lupus 
Erythematosus Quality of Life (Lupus QoL) questionnaire (Jolly, 2005), and the 
Systemic Lupus Erythematosus Needs Questionnaire (SLENQ) (Moses, Wiggers, 
Nicholas, & Cockburn, 2007).  
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The BILD questionnaire is used to identify organs and functions that have been 
permanently damaged as a result of their lupus. The more items marked, the higher score 
of lupus damage (Yazdany et al., 2011). 
 The Lupus QoL questionnaire is a 40-item survey using a Likert-scale from 1 
(“not difficult at all,” “not troubled at all,” or “not at all”) to 7 (“extremely difficult,” 
“extremely troubled,” or “extremely often) intended to measure quality of life based on 
problems with physical health and function, emotional and mental health, bodily pain and 
fatigue, social functioning, and medical treatment relating to their lupus. Higher scores in 
each item reflect greater disturbance, thus lower lupus-related quality of life (Jolly, 
2005).  
The SLENQ is an 85-item self-report scale for lupus patients in which participants 
indicate what categories of daily living they require a high need of support for, using a 
Likert-scale from 1 (“no need”) to 5 (“high need”). The categories are physical needs, 
daily living needs, psychological/spiritual/existential needs, health service needs, health 
information needs, social support needs, and employment needs. The more items marked 
suggests a higher need for support for the patient (Moses et al., 2007). 
Participants completed either a hard copy version of the survey or an online 
version hosted by Survey Monkey. The surveys completed on paper were entered into 
Survey Monkey by the researcher. 
Sample and Recruitment 
An appropriate sample size for a qualitative study is one that adequately answers 
the research question when new categories, themes, or explanations stop emerging from 
the data (Crouch & McKenzie, 2006; Marshall, 1996; Patton, 1990). Given the low 
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prevalence of SLE (Feldman et al., 2013), the exploratory nature, limited resources, and 
the time constraints of this study, it was estimated that we needed to recruit 10 – 20 key 
informants from a convenience pool of women 18 years or older with a confirmed 
diagnosis of lupus for at least one year. We believe one year of a confirmed diagnosis of 
lupus would be sufficient for participants to have a breadth of experience with the disease 
and with patient-provider interactions. Males and adolescents under the age of 18 were 
excluded. The final sample included 11 women with lupus meeting those criteria. After 
interested participants were identified, they read a consent form and stated their verbal 
agreement preceding the interview. The interviews were audio-recorded and conducted 
either in person at a public location or over the phone. Following the interview, each 
participant filled out a questionnaire.  
Procedure 
 Each interview was transcribed verbatim by the researcher. The information from 
the audio-recordings was linked to the matching questionnaire by using a participant ID. 
Each transcript was read and annotated repeatedly. After first impressions were made, 
labels for codes emerged that reflected more than one key thought. Related codes were 
then collapsed into meaningful topics. This process was repeated until the researcher 
(MVB) and research mentor (PV) corroborated the overarching themes from the data. 
The study was approved by Arizona State University’s institutional review board. 
RESULTS 
Participants 
 The sample included 11 women with lupus; ten participants had SLE, one out of 
those ten participants had lupus nephritis in addition to SLE, and one other participant 
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had cutaneous lupus erythematosus (CLE). Since the symptoms and patient-provider 
experience of the participant with CLE were comparable to the experiences faced by the 
rest of the women with SLE, she was included in the analysis. Ages ranged from 18 – 65 
(M = 34.36, SD = 16.27), and the number of years since diagnosis ranged from 2 – 13 (M 
= 5.64, SD = 3.83). Seven out of the eleven participants were non-white or of mixed race. 
Three out of the eleven interviews were conducted over the phone. The results from the 
BILD questionnaire indicated only three participants reporting bodily damage caused by 
lupus; one reported an episode of transverse myelitis, another reported an episode of 
transverse myelitis, seizures, and a cataract, and another reported a cataract. Scores on the 
Lupus QoL ranged from 53 – 185 (M  = 114.45, SD = 46.07), and scores on the SLENQ 
ranged from 45 – 178 (M = 92.91, SD = 46.33). A total of six participants scored above 
the mean on the Lupus QoL and four participants scored above the mean on the SLENQ, 
suggesting lower lupus-related quality of life and a higher need for support due to lupus. 
In addition, only two participants scored at least one standard deviation above the mean 
in both the Lupus QoL and the SLENQ. The complete survey results can be found in 
Table 1.  
Data Analysis 
Six overarching themes with several subthemes emerged from the data: 1) 
difficulties that accompanied a formal diagnosis of lupus included three subthemes 
1.1) delay of diagnosis, 1.2) getting misdiagnosed with another condition, and 1.3) 
having to fight to receive a diagnosis; 2) discovering that lupus is a process included 
2.1) experiencing fatigue and pain regularly, 2.2) learning that lupus makes one’s life 
unpredictable, 2.3) feeling inadequate and/or depressed, and then 2.4) accepting one’s 
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own limitations; 3) managing lupus requires 3.1) planning activities and life events 
ahead of time to care for symptoms, 3.2) listening to one’s own body (i.e., recognizing 
when it is time to rest), 3.3) dealing with the limited amount of information on lupus and 
lupus self-care, 3.4) learning to navigate the Internet to find information about lupus and 
lupus self-care, and 3.5) learning about the condition via other patient experiences; 4) the 
social impact of having lupus involves patients receiving both 4.1) instrumental and 
emotional social support, but also 4.2) facing the consequences of others being 
uninformed about lupus; 5) communicating the experience of lupus involves 5.1) 
educating others about lupus and 5.2) relating the information in ways others who do not 
have lupus can understand (e.g. spoon theory; Miserandino, 2003); and finally, 6) 
limitations within the healthcare system includes patients having 6.1) difficulties 
getting doctor appointments ahead of time, 6.2) facing problems with doctors, 6.3) having 
to find new doctors, and 6.4) developing a partnership with current doctors.  The findings 
are presented in Table 2 by themes and subthemes.  
Difficulties with Diagnosis 
 The participants described challenges they faced throughout the process of being 
diagnosed with lupus. In general, it is rare to have an official diagnosis of lupus as soon 
as symptoms occur because symptoms such as fatigue and pain can pertain to a number 
of different conditions. As a result, many of the participants reported a delay between 
seeing a physician for lupus-related symptoms and being formally diagnosed with lupus:  
“They thought that it was a number of things before they thought that it was 
lupus…So I was actually not formally diagnosed with lupus until I was 16 which 
is about 14 years later and it was about four or five doctors later.” (Participant 9, 
age 23) 
After two years of experiencing severe symptoms, Participant 7 (age 19) stated, 
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“…[the doctor] diagnosed me with lupus and said I’ve had it for a long time…”  
Other challenges included some trial and error with the diagnosis or patients being 
misdiagnosed with other conditions:  
“I would see a neurologist and the neurologist thought it was multiple sclerosis, 
and he said I had MS-like symptoms but nothing concrete. So he just said ‘Oh, it’s 
fibromyalgia.’” (Participant 3, age 34) 
 
After going to the hospital due to severe pain, Participant 5 (age 21) reported,  
“…they thought I was in a car accident, or that someone or something had hit 
me…but at the same time there was no injury.”  
 
Some of the women also described their experience of having to insist for doctors 
conduct more blood tests: 
“…[my doctor] found [having lupus] a bit far-fetched and you know I told 
her…just humor me.” (Participant 4, age 50) 
 
“…leading up to the diagnosis…it took a lot of fighting on my part to actually 
keep going to doctors because I said, ‘No, I know something is wrong with my 
body, there is something wrong.’” (Participant 7, age 19) 
 
Discovering Lupus is a Process 
 Following the process of being officially diagnosed with lupus, participants 
described the progression of their disease along with the struggles they have faced when 
experiencing new or existing symptoms. As a whole, participants suffered from fatigue 
and/or pain regularly:  
“It’s the strangest feeling to just be asleep for 12 hours and you just cannot get 
yourself up and going.” (Participant 2, age 42) 
 
“…there’s no day without pain…right now my hand is practically asleep 
because…I woke up with a lot of shoulder pain.” (Participant 5, age 21) 
 
Some participants also reported dealing with a sense of uncertainty in relation to living 
with lupus:  
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“… I never know if I’m sick like normal sick or if I have the cold or flu or 
whatever [or] if it’s the lupus.” (Participant 1, age 28) 
  
“[The most challenging aspect is] not knowing what day is gonna be a good day 
and what day is gonna be a bad day.” (Participant 4, age 50) 
 
In addition to dealing with uncertainty, the participants’ adjustments to the limitations 
placed on their lives because of lupus varied. Some expressed the challenges of managing 
lupus properly and lamented the loss of their previous life:   
“…you have no control over your body, you’re sick more often it seems, you’re 
suppressing your immune system but also trying to boost it, I mean it goes back 
and forth.” (Participant 2, age 42) 
 
 “So I went from doing all kinds of adventurous things to just doing nothing, just  
spending days lying in bed. I used to read a lot of books and research places to 
go, things to do and…it stopped.” (Participant 3, age 34) 
 
Others communicated feeling inadequate because they are unable to do the things they 
want to do: 
“Well sometimes the sleeping in makes me feel like I’ve wasted my day, which is 
kind of a hit on my self-esteem.” (Participant 11, age 23) 
 
“I feel like I want to do things and I just can’t do them. And it seems to me I am 
being lazy and that’s why I can’t do them and so that’s not a very good feeling. 
Why am I so lazy?” (Participant 8, age 65) 
 
Four participants explicitly reported having experienced depressed feelings as a result of 
the limitations placed on their lives because of lupus: 
“Well most of the time I continue doing my everyday things…but I look tired, very 
tired, and sometimes I get depressed…because my body is telling me to stop.” 
(Participant 6, age 55) 
 
“…I got really depressed because it kinda sucked. I was told that I couldn’t do a 
lot of things anymore; I’d have to go on all these medications…” (Participant 11, 
age 23) 
 
Not surprisingly, most participants described struggling coming to terms with the life-
changing diagnosis:  
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“I feel like I’m never gonna have my life back and I, realizing that this is the best 
it’s gonna be, it’s never gonna go back to where I was, where I had lots of energy, 
I think that is the worst part is accepting that things are not going to be the same” 
(Participant 2, age 42) 
 
“…you’re never gonna get better, there is no cure, you know the best you can do 
is be on medication for the rest of your life to manage it but you know you’ll 
always have it. And then trying to find purpose in life after that.” (Participant 11, 
age 23) 
 
On the other hand, a couple participants noted that being limited simply means finding an 
alternative path to achieve goals: 
“…you can do anything like anybody else. It’s just you can do it differently.” 
(Participant 5, age 21) 
 
“…you can still be everything you’ve always wanted to be, and you can do all of 
the things you always wanted to do. They just may not happen in the time you 
want them to.” (Participant 11, age 23) 
 
Managing Lupus 
 
Although lupus requires major life changes, the women discussed the ways in 
which they coped with their new obstacles; overall, many of the participants had to learn 
that stress plays a huge role in the onset of a flare-up. In addition, participants explained 
how they must keep in mind that flare-ups are always a possibility, meaning they must 
plan to be sick. For some, this may be something simple such as avoiding outdoor 
activities: 
“…just staying out of the sunlight [helps me to avoid flare-ups] because…the sun 
really irritates my skin.” (Participant 9, age 23) 
  
“I have to decide how warm is the day or how cold is the day, how warmed up 
are my joints in order to do something like [bike riding]. People will say, ‘well 
let’s go for a hike,’ I know I’m out.” (Participant 4, age 50) 
 
Sometimes planning to be sick requires deciding against a big life change: 
 
“I actually didn’t go to college with my scholarships that I got [for]this college in 
Michigan because I wasn’t feeling well and they had like the worst winter that 
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year too. So my parents were scared that I would go and not know what’s going 
on with my body.” (Participant 5, age 21) 
 
All participants reported that relaxing or “taking it easy” was their first line of defense 
when they felt a flare-up coming on. However, it is a learning process figuring out how to 
recognize triggers and knowing when to stop and rest, or as Participant 1 put it, learning 
to “listen to your own body.” 
“…if I know that I’m not feeling well, then I try not to make any plans like social 
plans or any other kinds of plans I just…basically plan to rest.” (Participant 1, 
age 28) 
 
“Knowing from the beginning what’s causing pain [is important] because your 
body is like a machine. You put something in and…something’s gonna come out, 
so knowing what [is] causing [flares] – for example I cannot be in the sun.” 
(Participant 5, age 21) 
 
Since it takes more than intuition to learn about one’s own body, Participants 2 and 9 
recommended keeping track of symptoms in a journal. This aided in making connections 
between past symptoms and current triggers: 
“I keep a record of what went on because what you find is…you may have been 
having symptoms and you didn’t even know it…[write] your flares and what you 
think may have triggered it I mean I wrote all my stuff down…sometimes things 
are related that you don’t realize are related so you write everything down” 
(Participant 2, age 42) 
 
“…definitely keeping a journal I think is really helpful. There is some stuff that I 
was curious about so I just had a notebook…I was curious so I started 
documenting [my menstrual cycle] and then there was a clear link between 
them.” (Participant 9, age 23) 
 
Even so, participants are not likely to always have an explanation regarding their own 
flare-ups or symptoms. Therefore, they commonly use the Internet as a source to either 
find the cause of their symptoms or how to manage them. Yet they still encounter 
difficulties navigating the Internet whether for lack of information about lupus or for 
having to sift through poor-quality information: 
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“Sometimes I look online but it’s hard to look online when there’s a lot of [crap] 
online.” (Participant 1, age 28) 
 
“…maybe it’s because lupus is an enigma, I mean there are so many symptoms in 
people and so many different things going on. I find it hard to find any good 
information.” (Participant 2, age 42) 
 
“[Websites] say okay [lupus] attacks your organs, and you can have this, but so 
many…sites act like you just have this big scar on your face that you just have to 
deal with because they say ‘Oh but many people with lupus just go on with their 
lives and have fulfilling lives,’ like they don’t tell you what really happens 
through this.” (Participant 3, age 34) 
 
“Do not…do research online, if you say you have a headache…they are telling 
you that you’re dying too.” (Participant 5, age 21) 
 
“…it’s like really hard I think, even though the lupus foundation does have a lot 
of information and a lot of different articles and about all types of things with 
lupus, it’s still not enough because I mean the problem is there’s not enough 
research” (Participant 10, age 18) 
 
Because of the difficulties finding information on the Internet, some participants reported 
benefitting from learning about other patient experiences:  
“Get to your nearest local support group. I think they are so informative. I’ve 
been a nurse for almost 25 years but…I knew nothing about lupus.” (Participant 
4, age 50)  
 
“…I had to go to [lupus] support group meetings to see people in 
wheelchairs…You know you have to find out from our lupus support group 
facilitator, I didn’t know you could end up in a coma, I didn’t know all these other 
things could happen” (Participant 3, age 34) 
 
While most participants found information from other patients with lupus, Participants 5 
and 6 recognized the fact that certain lupus manifestations can resemble other conditions; 
thus, they looked up what patients with other chronic illnesses do to treat their symptoms: 
“Honestly I get my information from other diseases…[I look up] exercises for 
rheumatoid arthritis patients or stuff like that... I have a lot of joint pain and a lot 
of muscle pain so…I look up, for example yoga, how [you can] stretch…or what 
types of exercises for muscle pain or chronic pain and skin problems like with 
rashes, how to prevent, stuff like that. I don’t really look up lupus.” (Participant 5, 
age 21) 
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“[Side-effects] can affect my heart or my bones or my kidneys so I read about 
those other illnesses…” (Participant 6, age 55) 
 
Social Impact 
 
 In addition to their own self-care behaviors, participants reported sometimes 
requiring outside assistance to help manage their condition, such as receiving the help 
from friends and family. Participants who reported that friends and family helped them 
did so by allowing them to rest, making their work-load lighter, being available for 
emotional support, and validating their concerns: 
“…they just do…everyday things for me. Like bring me food or just be around to 
take me to appointments or the hospital or whatever…it helps that they  
aren’t mad when I’m not able to do things.  And they understand if…I can’t do 
[activities], I’m just gonna sleep [that] day.” (Participant 1, age 28) 
 
“My husband [understands] because he…has lived with me all his life so he 
knows how I was and how I am…he will try to take care of things that I can’t do. 
Like things around the house like the wash or he’ll do the dishes.” (Participant 8, 
age 65) 
  
“[My friend] will kind of talk me through [my flare] and just let me vent and let 
me talk about it and then usually once I talk about it, it gets easier…the most 
helpful thing is just support. ‘Okay I’m here for you, if you want to vent go 
ahead.’ Or if I am with them just sometimes sitting with me or hanging out with 
me in bed or doing little things…” (Participant 7, age 19) 
 
Participant 2 (age 42) found that having someone to try new self-care activities with 
proved to be helpful as well: 
“Well my mom, she looks out for me…we do things together like a diet change 
and we…try this thing, see if it makes us feel better. So that’s someone who’s 
willing to make changes with me and then we test it on each other.”  
 
However, because of the drastic changes that follow a lupus diagnosis, it is not surprising 
that some family/friends have trouble understanding the experience: 
“…they forget that sometimes I’m tired and I need to stay home. Even if I want to 
go out, so sometimes they don’t understand that. And I try to explain it to them; I 
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tell them to go even if I don’t feel well. And so I don’t know if they really 
understand how a person with lupus feels because they don’t have it.” 
(Participant 6, age 55)   
 
“…people [think] that you’re better now, well I’m better yeah but I’m not yet 
well.” (Participant 8, age 65) 
 
“… just as I can’t fathom people not having pain, normal people can’t fathom 
having pain all the time.” (Participant 11, age 23) 
 
A few participants spoke about situations where these misunderstandings led to 
family/friends being insensitive to the fact they have limitations: 
“My mom was like ‘you’re not better yet? I thought that would be done already. 
Why are you still walking like that?’ and…’Oh my friend of a friend has lupus 
and she’s skinny…you can’t tell she has lupus, she doesn’t walk with a cane…’” 
(Participant 3, age 34) 
 
While the literature suggested patients might have problems with social support due to 
symptom invisibility, there were only two participants who explicitly stated that this was 
distressing to them:  
 “I think the biggest thing is people say, ‘well you look fine, so you must be fine.’ 
And that is probably my biggest trigger for getting me upset because [lupus] is 
an invisible disease and I am in constant pain. But lupus patients and anyone with 
an invisible disease have learned how to fake it. Because if you don’t fake it, 
people aren’t gonna wanna be around you.” (Participant 7, age 19) 
 
“The ‘you’re so young, you can’t have disorders’ you know I have a handicapped 
placard for my car, the looks and stuff you know…sometimes for people with 
invisible illnesses like that, just getting up in the morning is their biggest 
accomplishment of the day.” (Participant 11, age 23) 
 
Communication 
 
 As previously stated, communication is an important tool for conveying 
information to others so they may understand the experience of having lupus. The 
participants discussed ways in which they effectively communicate their experience to 
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others. Some participants noted that in order to communicate in a way others could 
understand, they had to find their own phrases or words that were compelling to them: 
“Find those phrases that become meaningful to you and your friends or your 
family so that you kind of, not like your own language but like you have your own 
subtext.” (Participant 11, age 23) 
 
“…really keep it simple. ‘Autoimmune’ was really the key word for me. And then 
some simple identifiers of how it affects them.” (Participant 9, age 23) 
 
Some reported that simply educating others and being honest about their experiences was 
enough to get people to understand, while others utilized analogies to make the 
experience more relatable to the general population: 
“…what I do, it’s like you’re having the flu but without mucus and coughing. 
Your body feels like that, aching the whole time, but I also tell them it’s like 
having a bruise and you can’t touch it.” (Participant 5, age 21) 
 
“I tell them it’s basically like when I have the swelling and pain in my legs, I try 
to say it’s like having a huge mosquito bite in the back of your knees or I tell them 
it’s like being pregnant and having all the worst symptoms of pregnancy.” 
(Participant 3, age 34) 
 
Participants 10 and 11 discussed using the “spoon theory” to explain the experience of 
having lupus to other people. The spoon theory primarily illustrates the act of having to 
plan each action ahead of time and sacrificing simple day-to-day activities so as to not 
over-exert the body (Miserandino, 2003):  
“…with lupus you wake up in the morning with [for example] 15 spoons. And 
everything that you do takes off one spoon. Getting up out of bed and getting 
dressed, that’s a spoon. Making your breakfast, brushing your teeth, that’s a 
spoon. And at the end of the day you have one spoon left. And so in my house I 
have three roommates, I’ll come home and my roommate will come in my room 
and she’ll ask me, ‘how many spoons do you have?’ I’m like ‘well I don’t know, 
one or two why?’ She says ‘Well I wanted to go out shopping. Do you wanna 
come with me?’ And I’m like ‘yeah I guess.’ And then some days I’m just like ‘I’m 
going to bed’, and she says, ‘Oh no spoons, okay.’” (Participant 11, age 23) 
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Limitations with the Healthcare System 
 
 The spoon theory and other analogies were useful for explaining the experience of 
having lupus to friends and family members. However, barriers regarding communicating 
with physicians seem to be distinctly different than the ones patients face with the 
individuals closest to them. Because patients with lupus often have symptoms they do not 
understand, it is important for them to maintain constant communication with their 
healthcare team, which often includes several different types of doctors, including but not 
limited to their primary care physician, rheumatologist, neurologist, cardiologist, and 
dermatologist. Yet some women reported difficulties getting appointments with doctors 
once concerns would arise: 
“…just waiting for the doctors [has been challenging] because sometimes I don’t 
feel well and I’m like well I need blood tests, I need doctors to look at me, I need 
this taken care of, and I have to wait for an appointment or whatever and I don’t 
want to wait I just want to be taken care of immediately.” (Participant 1, age 28) 
 
“…the pain in my hands and my wrist was so bad that I couldn’t even brush my 
teeth and I had to go from nothing to something I knew I had to get in. And you 
know to get into see a rheumatologist...it takes 4 to 5 months to get in if you’re a 
new patient…” (Participant 2, age 42) 
 
Aside from it being difficult to get an appointment with physicians, Participant 8 (age 65) 
also described the struggle of receiving information from doctors at certain time-points: 
 “…if I call in between it’s difficult to get information in between appointments.” 
However, once participants were actually able to meet with their physicians, all voiced 
concerns about a multitude of issues ranging from a lack of communication, a lack of 
treatment, and a lack of respect coming from the physician. Participant 2 (age 42) 
describes her experience of a physician failing to inform her about simple treatments that 
would help with common lupus symptoms: 
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“I had to do some research and then I had asked her to check my vitamin D…and 
it was significantly low…I found just by taking vitamin D I saw a lot of 
improvement that she didn’t, that should be like the first thing you ask…I’m like 
losing all this hair and [my doctor just said] ‘oh just take folic acid.’” 
 
Participant 3 (age 34) discussed a time when her doctor delayed reporting the results of a 
test, which interfered with treatment:  
“So months later…I finally get to see the MRI results…which means I finally get 
an appointment with the orthopedic surgeon because I couldn’t see him until I 
had the MRI. And he does x-rays and he says there is nothing we can do for you.”  
 
On top of not receiving treatment, some participants had mentioned wanting different 
types of information than what doctors were providing them, mainly concerning lifestyle 
and dietary information that could improve patient health from day to day: 
“…something else that I wish the doctors would explain…or maybe understand 
better, was the impact that food has on lupus and stress but also taking care of 
your body, your stomach.” (Participant 2, age 42) 
 
“…[doctors] tell me what medications to take and how to take them and 
everything like that. But in terms of…living a healthy lifestyle, none of them have 
ever said anything. So I kind of just figured it out on my own.” (Participant 1, age 
28) 
 
“I haven’t received a lot of information [from healthcare professionals] other 
than maybe if I was switching medications or they say ‘Okay this is this new 
medication, this is what it does’, otherwise I really had to figure out most of it on 
my own through my own research.” (Participant 7, age 19)  
 
Participant 1 (age 28) described a time when a doctor did not address her concerns as she 
would have liked, and speculated that collecting blood samples would have been a better 
alternative: 
“I knew I was getting a flare-up, and I went to a doctor, a rheumatologist, and 
told him all of my symptoms, which were quite a good amount of them…and he 
prescribed me pain medication and that was it. He didn’t order blood tests…with 
lupus…I think you have to take a look at what’s going on inside, you can’t just go 
off the symptoms.” 
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A few participants also encountered some physicians making inappropriate comments to 
them: 
“I had doctors accuse me of things and tell me that this was in my head and it was 
psychological and it wasn’t actual pain.” (Participant 7, age 19) 
 
“I don’t care how good the doctor is, if I cannot talk to them then you know it’s 
no good to me…I went to the doctors and he says ‘what are you doing  
here?’ Yeah obviously I didn’t go to see his face…and then pay him for it too.” 
(Participant 8, age 65) 
 
“I recently saw a cardiologist that the first 20 minutes of our appointment was 
him talking about how lupus doesn’t exist, and how it’s all stress, et cetera. That’s 
pretty brutal…having people talk about the illnesses I have as if they’re all made 
up is rough.” (Participant 11, age 23) 
 
Overall, a resounding piece of advice from the participants was if a patient is unhappy 
with a particular physician, they should not hesitate to find a new doctor. Furthermore, a 
few participants noted that acknowledging the fact that patients are the experts of their 
own health history can be effective in ensuring that they push for doctors to treat their 
symptoms: 
“…keep pushing for the doctors to do the blood tests and give you medications 
because a lot of times they just don’t…They think they know more than you and I 
know they’re doctors and they went to school but they don’t feel what you feel so 
like we’re not making it up. So just insist on getting the blood tests and the 
treatment.” (Participant 1, age 28) 
 
Moreover, participants described ways in which they partnered with at least one of their 
doctors. Once again, a few participants cited keeping a document of one’s own medical 
history, including symptoms, to show to their physicians. This allows for nothing to be 
left out and ensures that doctors are receiving all the information necessary about a 
patient’s symptoms even if the symptoms occurred prior to the actual appointment: 
“Keep a journal of all your symptoms and what the doctors say and the test 
results…because you have to every time you need a new doctor or whatever they 
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make you tell it over and over and over, and sometimes you leave stuff out or they 
don’t understand.” (Participant 3, age 34) 
 
“…whenever I have a new symptom or have pain or my joints swell up, I take a 
picture or I write it down. And then almost always I bring a list and it’s helped the 
relationship over the years a lot just so [my doctor] knew exactly what I was 
feeling on this day or he could see ‘okay this is what you’re talking about when 
you said it was swelling.’” (Participant 7, age 19) 
 
Although some participants expressed concerns about the difficulties with getting an 
appointment with a doctor at the time symptoms flared up, a few were able to circumvent 
this issue by contacting their doctors via telephone to call at any time with questions or 
concerns without having to make an appointment: 
“…[my doctor] gave me his cell phone number and his home phone number so 
that if anything was ever wrong, I could call him at any time.” (Participant 1, age 
28) 
 
“…[my doctor] is available by phone, I can call her with questions, she gets back 
to me within 24, 48 hours.” (Participant 9, age 23) 
 
All patients agreed that if doctors treated them with respect, it helped to develop a 
stronger partnership. The patient-doctor relationship also improved when patients had a 
say in their treatment options:  
“…[my] doctor was like, ‘Okay you have this option, and this option. This option 
is this, and this option is that, I recommend this option, but I know you’re gonna 
choose this one.’ So it’s like that because he knew me, so just having that 
relationship…he really wanted to help me out.” (Participant 5, age 21) 
 
“…I’ve dealt with this for over a decade so it’s not like I don’t understand my 
disease or my body so it’s very nice to be in control of my own health plan.” 
(Participant 11, age 23) 
 
Finally, some participants described an affinity to doctors who were able to speculate 
about their health outside of their respective discipline, thus being able to treat the 
patient’s health more globally. Because lupus is a condition that affects the entire body, it 
is not surprising that patients would find this trait in a doctor desirable: 
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“…nephrologists just deal with…kidneys, so even stuff that had nothing to do with 
kidneys, he was really knowledgeable about and he would help me and prescribe 
me whatever.” (Participant 1, age 28) 
 
“...[my doctor] said, ‘Your bloodwork is really good, but…you seem really 
stressed out and anxious so you need to get that under control and everything else 
will come.’” (Participant 2, age 42) 
 
“…if [my doctor] thinks my depression is getting the best of me she’s the first one 
to be like, ‘We need to alter your medications a little bit to help you’ or ‘You need 
to go see a counselor,’ something like that. She’s a very rounded physician 
knowing that medication is not the only answer.” (Participant 11, age 23) 
 
DISCUSSION 
 This study sought to explore the lived experiences of women with lupus using a 
qualitative approach, specifically, the experiences of dealing with patient-doctor 
relationships, perceived social support, and symptom invisibility. An additional goal of 
the study was to uncover self-management practices developed by women with lupus 
along the timespan of their condition, starting when symptoms were initially experienced 
prior to the formal diagnosis, including the specific barriers they encountered, the 
strategies they developed to solved them, and their recommendations for newly 
diagnosed women with lupus. From the testimonials, we identified six overarching 
themes: difficulties that accompanied a formal diagnosis of lupus, discovering that lupus 
is a process, managing lupus, the social impact of having lupus, communicating the 
experience, and limitations within the healthcare system. 
Consistent with previous research reporting that a diagnosis of a chronic condition 
is often accompanied by feelings of shock and confusion (Hale et al., 2006; Jefferies & 
Clifford, 2012; Kralik et al., 2005), our participants described a challenging process of 
being diagnosed with lupus. Also consistent trends with previous research, we found a 
general lack of awareness regarding lupus and its progression, a lack of information 
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available on lupus and lupus management, and issues managing relationships with 
physicians (Auerbach et al., 2013; Del Pino-Sedeno et al., 2016; Hale et al., 2006; Tench 
et al., 2000; Waldron et al., 2011). Regarding social support, participants reported 
benefitting from instrumental social support (e.g. friends/family helping with activities of 
daily living) and emotional support (e.g. having someone who will listen to and/or 
validate feelings). Although we were not able to confirm such relationships, there is 
evidence that such forms of social support are related to reduced disease activity and 
damage, and improved quality of life among patients with lupus (Mazzoni & Cicognani, 
2011). However, even for those who receive social support, educating family/friends who 
do not understand the challenges of having lupus remains a major issue in the life of 
women with lupus.  
While many challenging aspects in relation to having lupus were cited, a 
substantial portion of them included problems with the healthcare system, including 
physicians. These issues were prevalent throughout the lives of these women battling 
lupus, including early on when they were being diagnosed, when they were learning how 
to manage the condition, and when flare-ups arose.  
We did not identify potential explanations for poor patient-doctor relationships; 
however, previous studies suggest in some cases patients with chronic conditions faced 
difficulties with some physicians because of biases HCPs hold against specific patient 
characteristics or conditions (Ciribassi & Patil, 2016; Gysels & Higginson, 2008; Raine et 
al., 2004). Although previous research suggests patient-doctor relationships and social 
support might be affected by symptom invisibility (Hale et al., 2006; Kralik et al., 2005; 
Squance et al., 2014; Waldron et al., 2011), it is important to note that the majority of the 
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participants in this study did not explicitly mention symptom invisibility as the cause of 
any interpersonal problems faced.  
 A major concern among the study participants regarding HCPs was the fact that 
doctors did not fully address patient symptoms, potential management options, and side 
effects. In addition, some participants expressed concerns about not being able to 
schedule appointments soon enough even if their symptoms warranted a doctor visit. For 
a typical healthy patient, Urgent Care Centers and Walk-in Clinics might be an option; 
however, such establishments seldom have the resources to deal with patients who have 
lupus. These issues may suggest that currently, the medical system is unable to 
adequately care for patients with lupus.  
The Chronic Care Model (CCM) was developed as a framework for interventions 
in the healthcare system to manage patients who suffer from chronic conditions, 
including lupus.  The CCM’s goal is to help patients become informed and active 
participants of their health, and collaborate with a prepared and proactive healthcare team 
(Adams et al., 2007; Barr et al., 2003; Glasgow, Tracy Orleans, & Wagner, 2001; 
Moullec, Gour-Provencal, Bacon, Campbell, & Lavoie, 2012; Strickland et al., 2010). To 
achieve this goal, healthcare organizations must improve the clinical information system, 
as well as the resources to improve decision making, self-management, and linkages to 
pertinent community resources (Glasgow et al., 2001; Strickland et al., 2010). In addition, 
the whole healthcare team must be willing and prepared to deliver such care (Glasgow et 
al., 2001; Strickland et al., 2010).  
The few examples of partial implementation of the CCM into medical systems has 
shown positive results in the management of patients with various chronic conditions 
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(Adams et al., 2007; Moullec et al., 2012; Strickland et al., 2010). For example, via 
secondary data analyses from 25 different medical practices, Strickland et al (2010) 
found that patients with diabetes were more likely to obtain suitable diabetes care if they 
came from medical practices that utilized elements from the CCM. Similarly, reports 
from a systematic review support that using the CCM as a framework to inform 
healthcare delivery improved adherence to inhaled corticosteroids among adults with 
asthma (Moullec et al., 2012). Finally, another systematic review found that 
incorporating at least two principles from the CCM in practices treating patients with 
COPD was related to fewer emergency room visits, a lower likelihood of being admitted 
into the hospital, and shorter hospital stays, compared to patients who were in medical 
practices that did not incorporate such components from the CCM (Adams et al., 2007).  
In addition to the core elements originally proposed in the CCM; researchers 
proposed the Expanded CCM to address other factors that might influence health 
outcomes, such as a person’s cultural, environmental, and economic background. The 
Expanded CCM also incorporates community health promotion to develop the skills 
necessary to better control outside influences that contribute to poorer health in sick and 
healthy individuals alike. An example could be the community advocating for greater 
accessibility in homes, public transportation systems, and buildings to improve the 
quality of life for the elderly and for other individuals with physical disabilities (Barr et 
al., 2003). Such improvements in the community and the medical system may 
considerably help those with lupus; especially because the process to meet such 
improvements includes keeping patients informed, developing a culture in which 
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“healthy” individuals are familiar with the various obstacles others face on a day-to-day 
basis, and encouraging a positive patient-doctor working alliance.  
Although not yet tested, it has been suggested that drawing from elements of the 
CCM would benefit patients with lupus (Williams, Ortiz, & Browne, 2014), particularly 
because women of color, at higher risk for lupus, are often subject to health disparities 
(Auerbach et al., 2013; Gillis et al., 2007; Ortiz-Hendricks, 2012; Williams et al., 2014). 
For example, studies have shown that patients with lupus who use Medicaid travel longer 
to see their rheumatologist, thus are more likely to see a GP and also more likely to visit 
the ER (Gillis et al., 2007; Williams et al., 2014). Thus, adopting components from the 
CCM into community and healthcare systems could potentially improve the quality of 
life of patients with SLE by addressing barriers concerning travel and accessibility 
(Williams et al., 2014). A positive impact in the quality of life is also likely if preventive 
approaches rather than short-term treatments for acute flare-ups are incorporated in the 
management of lupus (Williams et al., 2014). 
Finally, it is important to note that changes that better inform patients about their 
condition, would address several concerns mentioned by the study participants. For 
example, many reported learning through experience, instead of through their HCPs, that 
stress triggered flare-ups and about simple treatments that could help common lupus side-
effects (e.g. taking folic acid for hair loss). Although each patient case is unique, there are 
enough commonalities between the study participants to suggest that more information 
should be provided about lupus to the patient upon diagnosis. The current study provides 
recommendations to newly diagnosed patients with lupus that may help them avoid some 
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confusion that accompanies managing a new condition and urges doctors to educate 
patients about self-care treatments earlier on.  
Conclusion 
The study utilized in-depth semi-structured interviews to collect the data, 
therefore it is inherently subject to a number of limitations. First, there was a small 
sample size and responses were self-reported, which means that these findings may not 
be generalizable to the rest of the patient population. Second, the participants in the study 
were not random; a handful of them were either acquainted with the researcher or shared 
a mutual acquaintance with the researcher. Third, participating in an in-depth semi-
structured interview is a fairly involved process. It is possible that our sample is 
particularly proactive in many aspects of their lives including with their health, which 
provides another reason for why we should not generalize these findings to the rest of the 
population. Fourth, due to the time constraints placed on this study, we could not 
continue collecting data from participants; consequently, we did not reach data saturation.  
Despite these limitations, this study provides new insightful recommendations 
that if incorporated into clinical practice, may not only help patients with lupus, but other 
patients as well. For example, maintaining a document to keep track of symptoms and 
learning from patient experiences outside of one’s own condition are some ways patients 
can participate in useful self-care strategies. These changes aim to benefit patients who 
are in need of care throughout their entire lives and who must be educated on how to 
independently manage their own health. 
In addition, these recommendations may inform cultural and policy changes 
necessary to improve healthcare delivery, including how HCPs may improve 
35 
 
relationships with their patients. Finally, future research should confirm the current 
findings and focus on discovering effective ways to best implement these changes as well 
as the effect of potential interventions incorporating these recommendations for the 
treatment of and the quality of life of patients with lupus. 
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Table 1. Participant Demographics 
Characteristic Number Percent 
Current Age 
18-25 
26-34 
35-42 
50-65 
Years since Diagnosis 
2 – 5  
6 – 9  
10 – 13  
Race/Ethnicity 
White/Caucasian 
Hispanic/Latina 
Black/African-American 
More than one race/ethnic identity 
Relationship Status 
Single 
In a relationship, not living together 
Married 
Previously married; now divorced 
Employment Status 
Employed full-time 
Employed part-time/Full-time student 
Homemaker 
Full-time student 
Employed full-time/On disability 
Combined Family Income 
$10,000 or less 
$10,001 - $20,000 
$30,001 - $40,000 
$40,001 - $50,000 
$50,001 - $60,000 
$70,001 and up 
I do not know/Refuse to answer 
 
 
5 
2 
1 
3 
 
7 
2 
2 
 
4 
3 
1 
3 
 
3 
3 
4 
1 
 
3 
1 
2 
4 
1 
 
2 
1 
2 
1 
1 
3 
1 
 
 
45.5 
18.2 
9.1 
27.3 
 
63.6 
18.2 
18.2 
 
36.4 
27.3 
9.1 
27.3 
 
27.3 
27.3 
36.4 
9.1 
 
27.3 
9.1 
18.2 
36.4 
9.1 
 
18.2 
9.1 
18.2 
9.1 
9.1 
27.3 
9.1 
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Table 1 (continued). Participant Demographics 
Characteristic Number Percent 
Number of Members in Household 
1 
2 
3 
4 
5 
6 
Subjective Rating of Health 
Poor 
Fair 
Good 
Type(s) of Lupus  
Systemic Lupus Erythematosus 
Systemic Lupus Erythematosus/Lupus Nephritis 
Cutaneous Lupus Erythematosus 
Lupus Damage 
Transverse Myelitis 
Transverse Myelitis, Seizure, Cataract 
Cataract 
Lupus QOL Sum 
50-70 
71-91 
92-112 
113-133 
134 and above 
SLENQ Sum 
40-60 
61-81 
125 and above 
 
 
4 
1 
1 
2 
1 
2 
 
1 
2 
8 
 
9 
1 
1 
 
1 
1 
1 
 
2 
2 
1 
2 
4 
 
4 
3 
4 
 
 
36.4 
9.1 
9.1 
18.2 
9.1 
18.2 
 
9.1 
18.2 
72.7 
 
81.2 
9.1 
9.1 
 
9.1 
9.1 
9.1 
 
18.2 
18.2 
9.1 
18.2 
36.4 
 
36.4 
27.3 
36.4 
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Table 2. Summary of Thematic Findings 
 
 
 
 
 
 
 
 
 
 
Themes and subthemes Participants quotes 
1. Difficulties with Diagnosis  
1.1. Delay of diagnosis So I was actually not formally diagnosed with 
lupus until…14 years later 
1.2. Misdiagnosis …they thought I was in a car accident or that 
someone or something had hit me… 
1.3. Fighting for diagnosis …leading up to the diagnosis…it took a lot of 
fighting on my part 
2. Discovering Lupus is a Process   
2.1. Fatigue/Pain …there’s no day without pain… 
2.2. Unpredictable nature of 
lupus 
… I never know if I’m…normal sick or…if it’s the 
lupus. 
2.3. Feelings of inadequacy & 
depression 
…I got really depressed because…I was told that 
I couldn’t do a lot of things anymore 
2.4. Accepting that lupus has 
limitations 
…you can do anything like anybody else. It’s just 
you can do it differently. 
3. Managing Lupus  
3.1. Planning ahead because of 
symptoms 
…just staying out of the sunlight because…the 
sun really irritates my skin. 
3.2. Listening to one’s own 
body 
…I basically…just plan to rest. 
3.3. Lack of information about 
lupus 
…lupus is an enigma…there are so many 
symptoms and…so many different things going 
on. 
3.4. Navigating the Internet for 
information about lupus 
…it’s hard to look online when there’s a lot of 
[crap] online. 
3.5. Learning from other 
patient experiences 
…[I look up] exercises for rheumatoid arthritis 
patients... 
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Table 2 (continued). Summary of Thematic Findings 
 
 
 
 
  
Themes and subthemes Participant quotes 
4. Social Impact  
4.1. Instrumental and 
emotional social support 
…they just do…everyday things for me. 
4.2. General lack of awareness 
about lupus 
…normal people can’t fathom having pain all the 
time. 
5. Communicating the 
Experience 
 
5.1. Educating others about 
lupus 
Find those phrases that become meaningful to 
you and your friends 
5.2. Relating information in 
ways others can 
understand 
…it’s like you’re having the flu but without mucus 
and coughing. 
5.2.1. Spoon Theory …with lupus you wake up in the morning with 
[for example] 15 spoons. And everything that you 
do takes off one spoon. 
6. Limitations with the 
Healthcare System 
 
6.1. Difficulty getting 
appointments 
...it takes 4 to 5 months to get in if you’re a new 
patient… 
6.2. Problems with doctors I had doctors accuse me…that this was in my 
head and…it wasn’t actual pain. 
6.3. Finding new doctors …if there is one thing you do and all that week, 
find another doctor… 
6.4. Partnering with doctors …[my doctor] gave me his cell phone 
number…so…I could call him at any time. 
48 
 
APPENDIX C 
SEMI-STRUCTURED INTERVIEW QUESTIONS 
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Thank you very much for agreeing to the interview, we believe that the information you 
share with us, can help us understand the lived experience of patients with lupus, and 
maybe develop better strategies to help them. Let’s start with your own story.  How 
did it start?  
 How long were you experiencing symptoms before you were diagnosed?  
 What type of symptoms did you initially experience?  
 Can you tell me about thoughts/worries you were having during the process of 
being diagnosed? 
 What has been the most challenging aspect of having lupus?  
 What advice would you give somebody that is in the initial stages of being 
diagnosed with lupus? 
Can you tell me about your experience with lupus-related symptoms?  
 How do you deal with the symptoms?  
 How has that affected your life?  
 Do you feel others understand your experience of having lupus?  
 Can you tell me how you explain your experience of having lupus to others?    
 What advice would you give somebody that is in the initial stages of being 
diagnosed with lupus regarding how to communicate with others about your 
illness and/or symptoms? 
Managing SLE can be overwhelming for some people. When your symptoms get 
worse, what do you do?  
 Do you have somebody who can help when the going gets tough?  
 How do others help you manage your condition?  
 What do they do for you that helps?  
 What would you like them to do that will make your life easier/better? What 
advice would you give somebody just diagnosed with lupus regarding how to 
manage the condition? 
How would you describe your working relationship with your doctor?  
 
Who would you say has been your best ally in the healthcare system?   
 Can you describe how you developed this partnership?  
 Did you see many healthcare professionals before finding this person?  
 What qualities make this person good? Can you talk about the 
problems/difficulties you experienced with other providers?  
 What advice would you give somebody that is in the initial stages of being 
diagnosed with lupus regarding how to find the right person to help?  
What do you think about the quality of information you have received about lupus 
care from healthcare professionals?  
 Has the quality changed since you were initially diagnosed? 
If you had any other advice for someone just diagnosed, what would it be?  
 
Is there anything else you’d like to add related to what we’ve discussed? 
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The following questionnaire asks about information related to your health, health 
care practices, and health needs. There are no right or wrong answers. First, we 
need to know a little about you. 
Current Age: ________________________________________________________ 
 
Race/Ethnicity: __________________________________________________________ 
Please check which best describes your current relationship status (check all that ap
ply): 
o Single 
o In a relationship, not living together 
o In a relationship, living with romantic partner 
o Married 
o Previously married; now separated 
o Previously married; now divorced 
o Previously married; now widowed 
o Other (please specify): 
Are you currently…? Check all that apply 
o Employed full-time 
o Employed part-time 
o Employed for wages 
o Self-employed 
o Out of work for more than 1 year 
o Out of work for less than 1 year 
o A homemaker 
o A full time student 
o Retired 
o On disability 
What is the combined (before taxes) family income for your household from all 
sources? Please mark one.  
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o Yearly income of $10,000 or less 
o $10,001- $20,000 
o $20,001- $30,000 
o $30,001- $40,000 
o $40,001 - $50, 000 
o $50,001 - $60, 000 
o $60,001 - $70, 000 
o $70,001 and up 
o I do not know/ refuse 
How many members are in your household including yourself? ________________ 
Would you say that in general your health is: 
o Excellent   
o Very good  
o Good  
o Fair  
o Poor 
 
Age of lupus diagnosis: ___________________________________________________ 
 
What type(s) of lupus do you have?  
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BILD  
This survey collects information about symptoms you may have experienced related to 
your lupus. In each box, please check “Yes” if you have experienced such symptoms, 
“No” if you have not experienced such symptoms, or leave blank if you are unsure.  
 
Ocular Yes  No 
Has a doctor ever told you that you had any of the following conditions 
or symptoms? 
  
 
1. Has an eye doctor ever told you that you had something wrong with 
the retina of your eye because of your lupus? (note: The retina is the 
back of your eye) 
  
2. A cataract in your eye?   
Neuropsychiatric   
3.  A psychotic episode?   
4.   Seizures?   
 If yes:  Did you ever have to take medication for seizures for at least 
6 months? 
  
5.  Stroke?   
 If yes: Did you ever have more than 1 stroke at least 6 months apart?   
6.  Paralysis in your arms or legs that was so severe that you needed to 
be hospitalized?  
(note: This is transverse myelitis, a rare condition caused by 
inflammation of the spinal cord). 
  
  If yes: Was this paralysis from a stroke or multiple sclerosis?   
Renal   
7. Have you ever had a kidney transplant?   
8. Have you ever been on dialysis?   
Pulmonary   
Has a doctor ever told you that you had any of the following conditions 
or symptoms? 
  
9. Pulmonary hypertension, which is high blood pressure in the lungs?  
This is different from regular hypertension or high blood pressure.  
  
10. A serious condition of your lungs, such as fibrosis or interstitial lung 
disease?  This does not include pneumonia, asthma, emphysema, or 
pleurisy.  (note: also not COPD, or bronchitis) 
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Cardiovascular   
11. Have you ever had coronary or heart bypass surgery?   
Have you ever been told by a doctor that you had any of the following 
problems? 
  
12.  Heart disease, including angina or congestive heart failure?   
13.  Heart attack?   
 If yes: Did you ever have more than 1 heart attack at least 6 months 
apart? 
  
14. An episode of pericarditis, which is an inflammation in the sack 
around the heart, that lasted 6 months or longer? 
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Lupus QoL – The following questions ask about the day-to-day problems that can affect 
SLE patients. There are no right or wrong answers. Mark an X in the box that best 
demonstrates its importance in your life. 
How difficult has each of these activities been in the last week as a result of 
your SLE? 
 Not 
diffic
ult at 
all 
Hardy 
diffic
ult 
Somew
hat 
difficult 
Moderat
ely 
difficult 
Quite 
diffic
ult 
Very 
diffic
ult  
Extrem
ely 
difficul
t 
N/
A 
1. Walking 
outdoors on 
level 
ground. 
        
2. 
Shopping. 
 
        
3. Turning 
taps on and 
off (or 
faucets) on 
and off.  
        
4. Going to 
the 
supermarket 
(grocery 
store). 
        
5. Bathing 
and drying 
yourself. 
        
6. Walking 
2 miles. 
 
        
How troubled have you been in the last week by each of these social or 
occupational activities as a result of your SLE? 
 
 Not 
troubl
ed at 
all 
Hardl
y 
troubl
ed 
Somew
hat 
trouble
d 
Moderat
ely 
troubled 
Quite 
troubl
ed 
Very 
troubl
ed 
Extrem
ely 
trouble
d 
N/
A 
7. Work and 
school 
performanc
e. 
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8. 
Interference 
with your 
career or 
education.  
        
9. Missing 
work or 
school. 
        
10. 
Relationshi
p with 
friends and 
relatives. 
        
11. Taking 
part in 
sports. 
        
12. Sexual 
activities. 
 
        
13. Taking 
part in 
social 
activities.  
        
14. Unable 
to go out in 
the sun. 
        
15. 
Earning/ma
king less 
money 
because I 
have SLE. 
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How troubled have you been by each of these symptoms in the last week as a 
result of your SLE? 
 Not 
troubl
ed at 
all 
Hardl
y 
troubl
ed 
Somew
hat 
troubled 
Moderat
ely 
troubled 
Quite 
troubl
ed 
Very 
troubl
ed 
Extreme
ly 
troubled 
N/
A 
16. Poor 
memory. 
 
        
17. Loss of 
appetite. 
 
        
18. Fatigue. 
 
        
19. Poor 
concentrati
on. 
        
20. Itchy 
skin.  
 
        
21. Sore 
mouth. 
 
        
22. Sore, 
painful, or 
stinging 
skin. 
        
23. Joint 
pain and 
swelling. 
        
How troubled have you been by each of these problems related to medical 
treatment in the last week as a result of your SLE? 
 Not 
troubl
ed at 
all 
Hardl
y 
troubl
ed 
Somew
hat 
troubled 
Moderat
ely 
troubled 
Quite 
troubl
ed 
Very 
troubl
ed 
Extreme
ly 
troubled 
N/
A 
24. Fear of 
needles. 
 
        
25. Dietary 
restrictions. 
        
26. 
Inconvenie
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nce of daily 
medication. 
27. 
Inconvenie
nce of 
frequent 
clinic visits. 
        
How often during the last week have you been troubled by these emotions as a 
result of your SLE? 
 Not at 
all 
Hardl
y ever 
Somew
hat 
often 
Moderat
ely often 
Quite 
often 
Very 
often 
Extreme
ly often 
N/
A 
28. Self-
consciousn
ess. 
 
        
29. Feeling 
low or 
down. 
        
30. 
Depression. 
 
        
31. 
Anxiety. 
 
        
How often in the last week have you been troubled by these feelings as a result of 
your SLE? 
 No
t at 
all 
Hardl
y ever 
Somewha
t often 
Moderatel
y often 
Quit
e 
often 
Ver
y 
ofte
n 
Extremel
y often 
N/
A 
32. I wish that 
other people 
did not know 
that I have 
SLE 
        
33. Being 
made fun of 
by my friends 
and 
colleagues. 
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34. Low self-
esteem. 
 
        
35. 
Embarrassme
nt about my 
SLE. 
        
36. Concern 
about the 
financial 
burden to my 
family. 
        
37. Concern 
that medicines 
do not work. 
        
38. Concern 
about side 
effects of 
medicines. 
        
39. Fear of 
receiving bad 
news from 
doctors. 
        
40. 
Consuming 
more alcohol 
or tobacco.  
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SLENQ  
The following questions ask about your need for support or care regarding your lupus 
condition. Indicate the extent and magnitude of your need for support or care in the 
previous 6 months using a 5-point scale: (1 = "no need," 2 = "need already satisfied," 3 
= "low need," 4 = "moderate need" and 5 = "high need") 
 No need Need 
already 
satisfied 
Low 
need 
Moderate 
need 
High 
need 
Physical 
Tiredness       
Pain        
Sleeping problems      
Headaches      
Skin rashes      
Dry mouth      
Shortness of breath      
Mouth ulcers      
Urinary frequency      
Dental health      
Daily Living Issues 
Work around home      
Shopping      
Food preparation      
Driving difficulty      
Writing problems      
Transport to appointments      
Speaking problems      
Reading difficulties      
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 No 
need 
Need 
already 
satisfied 
Low 
need 
Moderate 
need 
High 
need 
Psychological/Spiritual/Existential 
Unable to do what used to 
do 
     
Fears disease flare      
Anxiety and stress      
Feeling down/depressed      
Fears physical disability      
Uncertainty about future      
Changes in appearance      
Keeping positive outlook      
Feeling in control      
Feeling useless      
Health Services 
Reassurance of normality      
Open discussion with 
doctors 
     
Knowing when to see 
doctor 
     
Talking to a professional      
Rapid test result 
information 
     
Concerns to be taken 
seriously 
     
Information about 
treatment effects 
     
Discussion time with 
doctors 
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General practitioner 
understanding SLE 
     
Selecting medical help      
 
 No 
need 
Need 
already 
satisfied 
Low 
need 
Moderate 
need 
High 
need 
Health Information 
Information services and 
benefits 
     
Guidance on disease 
phase activity 
     
Obtaining self-help 
information 
     
Support for 
complementary therapy 
     
Relaxation classes      
Dietary information      
Getting written 
information 
     
Obtaining current 
information 
     
Drop in counseling      
Counseling services      
Social Support 
Explaining SLE 
unpredictability 
     
Others coping with SLE      
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Ability to participate in 
social activity 
     
Expressing feeling with 
others 
     
Coping with attitude 
changes to self 
     
Support from 
partner/children 
     
Maintaining friendships      
Maintaining family 
relationships 
     
Coping with change in 
sexual relations 
     
Sexual information for 
partner 
     
Employment 
Meeting extra costs of 
disease 
     
Meeting living expenses      
Maintaining job 
performance 
     
Gaining employment      
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APPENDIX E  
INFORMED CONSENT 
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Consent Form for Participation in a Research Study 
Arizona State University 
 
Lived experiences of women with systemic lupus erythematosus (SLE) 
 
Description of the research and your participation 
 
You are invited to participate in a research study conducted by Perla Vargas (PhD) and 
Miriam Vélez-Bermúdez (BS). You must be a female 18 years or older to participate, and 
have been officially diagnosed with lupus by a physician for at least one year prior to 
December 2015.  
The purpose of this research is to learn about the lived experiences of living with lupus in 
terms of support and physician care. 
 
Your participation will involve answering face-to-face interview questions about your 
illness and the support you receive. This may take 30 minutes to 3 hours, depending on 
your personal experience and the information you are willing to share. We would like to 
audio record the interview to look at the data more closely. Please let us know if you do 
not want to be audio recorded. You can change your mind after we start, just let the 
researchers know. Following the interview, you will be asked to complete a survey with 
questions related to your illness, health needs, and health behaviors. This may take 10 – 
20 minutes to complete.  
 
Risks and discomforts 
 
There are certain risks or discomforts associated with this research. They include being 
inconvenienced by taking the time to answer survey and interview questions. You may 
also experience discomfort when asked about your personal thoughts and feelings. Keep 
in mind you may withdraw from the study at any time, and you may refuse to answer any 
question if you wish. 
 
Potential benefits 
 
This research may help us to further understand certain risks and protective factors 
among women with SLE in terms of support. There are no known direct benefits to you 
as a result of your participation in this research. ASU West students participating in the 
study will receive SONA credits for their time. Each participant will receive 1 research 
credit for every 30 minutes or part of 30 minutes used for the interview. In other words, if 
the interview takes 45 minutes you will receive 2 research credits plus 1 credit for the 
time it takes to get to and from the location used for the interview.  
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Protection of confidentiality 
 
All answers will be kept confidential. Your contact information will not be linked to the 
interview or the data from the questionnaires. No visual images will be taken. All audio 
recordings will be deleted two weeks following transcription. All data will be kept on a 
password protected computer, in a locked laboratory of the principal investigator. We 
will do everything we can to protect your privacy. Your identity will not be revealed in 
any publication resulting from this study. 
 
Voluntary participation 
 
Your participation in this research study is voluntary. You may choose not to participate 
and you may withdraw your consent to participate at any time. You will not be penalized 
in any way should you decide not to participate or to withdraw from this study.  
 
 
Contact information 
 
If you have any questions or concerns about this study or if any problems arise, please 
contact Perla Vargas at 602-543-8224 or Miriam Vélez-Bermúdez at 614-678-2127. If 
you have any questions or concerns about your rights as a research participant, please 
contact the Arizona State University Institutional Review Board at 480-965-6788. 
 
Consent 
 
Your participation in the interview and filling out the questionnaire is considered 
your consent to take part in this research 
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APPENDIX F 
 
IRB EXEMPTION LETTER 
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EXEMPTION GRANTED 
Perla Vargas 
Social and Behavioral Sciences, School of 
602/543-8224 
Perla.Vargas@asu.edu 
Dear Perla Vargas: 
On 12/11/2015 the ASU IRB reviewed the following protocol: 
Type of Review: Initial Study 
Title: Factors mediating patient-doctor relationship 
among women with systemic lupus erythematosus 
Investigator: Perla Vargas 
IRB ID: STUDY00003576 
Funding: None 
Grant Title: None 
Grant ID: None 
Documents Reviewed: • Script inviting participation, Category: 
Recruitment Materials; 
• Consent form, Category: Consent Form; 
• HRP-503a-
TEMPLATE_PROTOCOL_SocialBehavioralV02-
10-15.docx, Category: IRB Protocol; 
• Interview questions, Category: Measures (Survey 
questions/Interview questions /interview 
guides/focus group questions); 
• Questionnaire for participants, Category: 
Measures (Survey questions/Interview questions 
/interview guides/focus group questions); 
 
The IRB determined that the protocol is considered exempt pursuant to Federal 
Regulations 45CFR46 (2) Tests, surveys, interviews, or observation on 12/11/2015.  
In conducting this protocol you are required to follow the requirements listed in the 
INVESTIGATOR MANUAL (HRP-103). 
Sincerely, 
69 
 
IRB Administrator 
cc: Miriam Velez-Bermudez 
Miriam Velez-Bermudez 
Agnes Bucko 
 
 
 
 
 
 
 
 
